Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform...

Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist VANCOUVER, British Columbia, April 04, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...

L'Université d'Ottawa améliore le niveau d'apprentissage et sécurise quatre-vingt dix-neuf pour cent du taux de participation grâce à Echo360 RESTON, VA--(Marketwired - 4 mars 2015) - Echo360, le chef de fil mondial de l'apprentissage actif, a annoncé aujourd'hui les conclusions du Dr Colin Montpetit de l' Université...

University of Ottawa Improves Learning Outcomes and Secures 99 Percent Participation Rate Using Echo360 RESTON, VA--(Marketwired - March 04, 2015) - Echo360, the global leader in active learning, today announced the findings of Dr. Colin Montpetit from the University of Ottawa regarding his...